NCT03480971 2024-11-20
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Matrix Biomed, Inc.
Phase 2 Recruiting
Clinical Trials
3 trialsNCT04262336 2023-07-06
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Decibel Therapeutics
Phase 1 Completed
NCT01451853 2017-09-25
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Sound Pharmaceuticals, Incorporated
Phase 2 Unknown